Latest News and Press Releases

DENVER, June 6, 2011 (GLOBE NEWSWIRE) -- Protea Biosciences, a leading developer of new bioanalytical technology, announced today that it has commenced offering the industry's first bioanalytical...

MORGANTOWN, W. Va., May 26, 2011 (GLOBE NEWSWIRE) -- Protea Biosciences, a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with...

NEW ORLEANS, Nov. 16, 2010 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leading developer of technology for biomolecular analysis, announced today that the company has completed an expansion of its...

MORGANTOWN, W. Va., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Protea Biosciences, a leading developer of new bioanalytical technology, announced today that the company has concluded an exclusive, worldwide...

MORGANTOWN, W.Va., June 22, 2010 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with...

MORGANTOWN, W.V., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company has been granted a...

MORGANTOWN, W.V., Nov. 23, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new technology for improved protein analysis, today announced that it has entered into a...

MORGANTOWN, W.Va., July 21, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences announced today that it has entered into an exclusive license agreement with Johns Hopkins University (JHU) for technology...

The Two Companies Will Collaborate in the Development of a New Biopharmaceutical for the Treatment of Exocrine Pancreatic Insufficiency (EPI) ...

MORGANTOWN, W.Va., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new protein research technology, announced today the commercial launch of its new protein...